chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The day I was vaccinated I had the usual soreness at the injection site and for the next day; Headache; Lymph nodes at the back of my neck were swollen; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ZN6205) via an unspecified route of administration in the arm left on 25Feb2021 at 15:45 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications taken within two weeks included fexofenadine hydrochloride (ALLEGRA) from an unknown date for an unknown indication. On 05Mar2021 at 03:30, on the day of vaccination, the patient experienced usual soreness at the injection site and for the next day. A week after she got the shot she got a headache so bad she had to take Tylenol for it but she also noticed her lymph nodes at the back of her neck were swollen, she called her daughter, she's working on her PHD in infectious diseases, and told her about her swollen lymph nodes and her daughter told her that she need to report it. The daughter told that means the vaccine was working and her body was doing what it's suppose to be doing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events vaccination site pain, headache and swollen lymph nodes and included treatment with paracetmol (TYLENOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vaccination site pain, headache and swollen lymph nodes was resolved in Mar2021.   No follow-up attempts are needed. No further information is expected.
The first day, I noticed a lot of saliva passing through my throat and then it went away. I also noticed a lot of exhaustion days later and throughout the whole month. After my second dose, I noticed I started having edema. I struggled with that for about a month. Then I ended up being diagnosed with nephrotic syndrome, minimal change disease and acute kidney injury. The cause was pretty much unknown. I don't have a history or kidney disease or anything like that.
With the second dose I had bad headaches, fever (99.9F), injection site got swollen after a couple of days, painful, had to use ice pack and it still hurts (not swollen anymore) ? symptoms were milder than 1st dose, heavy bleeding for an extended amount of time even with meds to try to stop it and the coloring was darker, brown, not really bright red as usual. I still have a little bit of headache not as bad as in the beginning and body aches and pains.
Dizziness. Initial BP 144/89 (pulse 86). Final BP 127/85 (pulse 68).
Itchy skin; This case was reported by a consumer via patient support programs and described the occurrence of itchy skin in a 75-year-old male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included hypertension (the patient was diagnosed with hypertension 10 years before the date of reporting).   On an unknown date, the patient received Shingles vaccine. In February 2022, between 7 and 9 months after receiving Shingles vaccine, the patient experienced itchy skin. On an unknown date, the outcome of the itchy skin was not recovered/not resolved.   The reporter considered the itchy skin to be unrelated to Shingles vaccine.  Additional details were reported as follows: The reporter was patient's spouse. The patient had shingles vaccine about 8 months ago but it was not through this program (P-55319505) and not sure if it was GlaxoSmithKline product. The patient had been itchy from the shingles on his whole body for two weeks now. The reporter consented to follow-up. The reporter declined to consent to follow-up with HCP (Health Care Professional).
Extreme irritability low grade fever beginning about 7 days after MMR administered progressing to rash and worsening irritability and arthralgia.  ER visit 08/17 dose due to irritibilaty both ne.
Information has been received from a licensed practical nurse referring to multiple unspecified patients of unknown gender and age. The patient's pertinent medical history, drug reactions/allergies and concomitant medication were not provided. On unspecified dates, the patients were vaccinated with improperly stored doses of ROTATEQ (lot # M004890, expiration date 10-NOV-2017, oral; dose was unknown). No adverse effects were reported. The reporter stated that the vaccines were exposed to 52 Fahrenheit degree for 15 hours and then they backed in range. There were no previous temperature excursion. No product quality complaint was involved. This is one of several reports received from the same reporter. Follow up information has been received on 17-SEP-2016. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.
After being stable for over a year, I went back into AFib the morning after my second dose. I went in and out for 9 days and then stayed back in a normal sinus rhythm since.  I monitored my condition with my Kardia 6L and reported the events to my Electrophysiologist via my on-line chart. They monitored me closely but were pretty sure it would settle out, which it did.  I would still take the vaccine again.
Swelling, induration, itching, redness, blisters at injection site. Initially 5 cm in size. This progressed over 2 days. Entire upper arm was swollen and red. Patient went to ER on 8/16/14. Was given prednisone and Benadryl. Swelling and induration are now resolving.
Administered expired vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine). On 22-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided.  Treatment information was not provided
Fever, chills, body aches starting around 1 an on 04/07/2021 lasting until around 8 am.  04/07/2021 daytime symptoms abated. Aches an pains but no fever returned at around 1 an on 04/08/2021 lasting most of the night. 04/09/2020 only muscle weakness noticable.
She said that she started having a headache, body aches, and some fever at about 2 am the morning after getting the vaccination.  She also lost her sense of taste and smell about 2 days later.
Took 6 days to get my energy back; Very bad body aches; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Took 6 days to get my energy back) and MYALGIA (Very bad body aches) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (hasn't been bad last year with the use of the mask.), Asthma (hasn't been bad last year with the use of the mask.) and Chronic bronchitis (had been good for two years). Concomitant products included CETIRIZINE for Allergy, VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced ASTHENIA (Took 6 days to get my energy back) and MYALGIA (Very bad body aches). On 24-Mar-2021, ASTHENIA (Took 6 days to get my energy back) had resolved. At the time of the report, MYALGIA (Very bad body aches) outcome was unknown.            No treatment information were provided.   This case was linked to MOD-2021-392250, MOD-2021-392574 (Patient Link).
Nausea/Vomiting, fever, chills, diarrhea, aching
7PM Dizzy, nausea, lite chill, weak 9:30PM vomit repeatedly, shaking uncontrollably, extreme cold, not able to walk, could not make efforts to get help till Sun. midnight w/unconscious some.
itchy; This is a spontaneous report from a contactable consumer (patient). An 80-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: EM9809), via an unspecified route of administration, administered in left arm (reported as left upper arm), on 25Feb2021 at 11:30 (age at vaccination was 80-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history included allergies to sulfa and penicillin. The patient's concomitant medications were reported as none. The patient previously took nitrofurantoin (MACROBID) and experienced allergy. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. On Mar2021, the patient experienced itchy. It was further reported that four or five days later after the vaccine, patient had itchy (no rash), just itchy. The patient's dermatologist prescribed triamcinolone acetonide cream 0.1% in the tube for 3-4 times a day as needed and was reported that it helped a little bit (it worked), but then it didn't work. It was reported that itchy had sort of tapered off, wasn't gone but had tapered off. The outcome of the event was recovering.  No follow up attempts are possible. No further information is expected.
3/17/21 ER Nurses' Triage note:  "To  Er via EMS for eval of AMS and low oximetry as reported by nurse at the rehab and long-term care facility. States he has not been his "normal " self the last few days. Upon arrival here patient is alert and verbal. Laughing with staff, poor extremity circulation shows varying oximetry, but after warm blanket applied oxi 99-100% 2lpnc. Is bradycardic with cardiac monitor showing 3rd degree block"
Arm soreness after injection, Right leg DVT - occlusive thrombus in the right popliteal vein as determined by peripheral venous ultrasound of the right leg on 03/01/2022. Patient had no prior change of medications, no travel, no extended time without movement, no trauma in the months prior to DVT
No additional AE.; Patient was administered improperly stored PNEUMOVAX23 Prefilled Syringe on 07/27/2021; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications or drug reactions/allergies was provided.  On 27-JUL-2021, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) prefilled syringe (lot number T039322 has been verified to be a valid lot number, expiration date reported and established as 09-SEP-2022) (dose, route and anatomical location of administration were not reported) for prophylaxis (product storage error).   The involved vaccine was exposed to a temperature excursion of 65 grades Fahrenheit (F) for 8 hours, as recorded by a data logger. There was not a previous temperature excursion. No additional adverse event was reported. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername:  devicelotnumber: T039322; expirationdate: 09-SEP-2022; deviceage and unit: 0 ; malfunction: Unknown; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
Starting 07/06/2022, I felt fatigued. Either that day or the next day, I felt a stuffy nose and a runny nose (one nostril being runny and one nostril being stuffy). Also, when I drank a glass of orange juice, it hurt my throat as if I was "drinking glass" so I knew something was wrong. I had coughing at night starting that Thursday or Friday (07/07 or 07/08). On 07/08/2022 I did a telehealth visit for a regular visit and I wanted to wait until 5 days post travel (I had returned from overseas) to test myself for COVID-19. After the visit, I did an at-home COVID-19 test the same day (because it was 5 days since I returned home) which was positive. So, I called my doctor back and they wanted confirmation that I was positive. So, I went to urgent care and got a PCR test done. It came back positive on the following Sunday (07/10/2022). I notified my employers on 07/08/2022 and the department of health called me to confirm I was isolating and advised me when to return to work. My symptoms had subsided by Monday (07/11/2022). I went back to one job on 07/12/2022 and then the school job on 07/14/2022 (because I had to wait until I tested negative).
pt recv vax 17FEB98 w/o difficulty;w/in 24hr redness & swelling of face & anterior neck assoc w/local pruritus & thickening;self rx w/DPH;
Information has been received from a Post-Marketing evaluation program for Rotateq concerning a 5 month old female who was vaccinated PO with her second dose of Rotateq. Subsequently 53 days post dose, the patient was admitted to the hospital with a 24 hour history of emesis and bloody mucous per rectum and remained hospitalized for 3 days. An air contrast enema demonstrated ileocolic intussusception to the level of the sigmoid. An exploratory laparotomy showed a necrotic cecum as well. The intussusception was reduced and an ileocecotomy was performed. The patient was discharged on day 3. The outcome was unknown. Intussusception was also considered to be an other important medical event by the reporter. Additional information has been requested.
Legs and arms broke out in a rash where the sun was in contact with them/Does the vaccine cause sensitivity to the sun; Arms and legs continue to blister and peal if I out in the sun; Arms and legs exposed to sun were extremely itchy; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOSENSITIVITY REACTION (Legs and arms broke out in a rash where the sun was in contact with them/Does the vaccine cause sensitivity to the sun), BLISTER (Arms and legs continue to blister and peal if I out in the sun) and PRURITUS (Arms and legs exposed to sun were extremely itchy) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa- Stomach pain) and Allergy to antibiotic (Amoxicillin- Hives).   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced PHOTOSENSITIVITY REACTION (Legs and arms broke out in a rash where the sun was in contact with them/Does the vaccine cause sensitivity to the sun), BLISTER (Arms and legs continue to blister and peal if I out in the sun) and PRURITUS (Arms and legs exposed to sun were extremely itchy). The patient was treated with HYDROCORTISONE on 06-May-2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, PHOTOSENSITIVITY REACTION (Legs and arms broke out in a rash where the sun was in contact with them/Does the vaccine cause sensitivity to the sun), BLISTER (Arms and legs continue to blister and peal if I out in the sun) and PRURITUS (Arms and legs exposed to sun were extremely itchy) had not resolved.            No relevant concomitant medication was reported.  Patient experienced symptoms like redness.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received and reporter details, patient demography and medical history, dosage information, treatment and events were updated.
Tired; Feeling unwell; Lethargy; Headache for 12 days post vaccine; This is a spontaneous report from a contactable Physician (patient himself). A 66-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection batch/lot no: EK5730 while expiration date: unknown), intramuscularly on the right arm on 21Dec2020 07:30 at a single dose for COVID-19 immunization.  The patient medical history was not reported.  There were no concomitant medications reported. The patient previously took meropenem and experienced allergies. On 21Dec2020, at 03:30PM (15:00), patient experienced tired, feeling unwell, lethargy, and headache for 12 days post vaccine. No treatment for adverse events were received. Outcome of the events tired, feeling unwell, lethargy, and headache for 12 days post vaccine was not recovered. Patient has no COVID prior vaccination and has not received any other vaccine within 4 weeks prior to COVID vaccine. Since vaccination, patient was not tested for COVID-19. The COVID 19 vaccine was administered in the hospital. The events were assessed as non-serious. The events resulted to physician office visit.
PATIENT COMPLAINED ABOUT ITCHING AND DIARRHEA/VOMITING ON THE WHOLE BODY 4 - 5 HOURS AFTER INJECTION.  PATIENT WENT TO THE EMERGENCY ROOM FOR STEROID SHOT TREATMENT AND BENADRYL.  HE WAS DISCARD 5 HOURS LATER WITH RXS FOR ZOFRAN AND PREDNISONE.
FEVER, RED FACE OR HIGH BLOOD PRESSURE, SEVERE ACHING ALL OVER THE BODY AND JOINTS, LOSS OF APPETITE, SLEEPLESSNESS, SEVERE SWEATING THROUGHOUT THE NIGHT SLEEPING, ACHING ARM, REDNESS AROUND INJECTION SITE, PAIN TO RAISE OR USE THE ARM.
Local arm redness, itching, induration at 24 hours with extension of redness to elbow mostly resolved by 4th day.
Per parents report on 3/7/00, pt has had increased temperature since yesterday of 102F. She is hoarse and has a sore throat. No vomiting, diarrhea or rash. She is complaining that her body hurts everywhere. Treated with aspirin. She was dx'd with bronchitis and treated with amoxicillin.
Vaccine #1. Headaches for 2 days, that would jump around in my head. These started occurring within 1/2 hour of the injections. Nothing I would even take an aspirin for, but as soon as it occurred, I recalled the same thing for a few days about 2 months earlier. Does this mean I had Covid already and was essentially asymptomatic? Would have been nice to have been tested for antibodies prior to the first injection. Vaccine #2. About an hour after the vaccine was administered, I was very fatigued. This fatigue has lasted ever since. The first 2 months, I could not do much without laying down after about 2 hours. The fatigue then started subsiding, but I am still not at my normal energy level. I have also had lower body muscle soreness, which is still occurring.
7 days later itchy rash , swelling  and hospitalization.  As of this date symptoms are still present but improved
11/12/21-left hip pain began; continued to worsen-very difficult to walk, especially go up stairs; from 11/12 until diagnosis on 1/19/22 condition progressively worsened until could not move in morning; could not move in bed; could not sit on soft chair; difficulty getting into and out of car; shoulders and buttock area felt frozen; unable to move for at least 4 hours a day; 11/23-left hip xray; 12/1 recd cortisone shot; 12/10-back xray- showed scoliosis (previously diagnosed 10 years ago); primary doctor recommended physical therapy; began PT on 12/20-PT not effective; 1/17/22 talked to rheumatologist who thought I had Polymyalgia Rheumatica (PMR); confirmed with blood test on 1/18/22 (results on 1/19/22); 1/19/22 began 20 mg prednisone
Information has been received from a consumer concerning her daughter (a 16 year old female) who in March 2008, was vaccinated with her first dose of GARDASIL.  About 24 hours after receiving the vaccine (March 2008), the patient felt like there was stakes going through her arms and legs for about 2 weeks after receiving the vaccine.  Caller stated it was intense pain and she had difficulty moving.  At the time of the report (23-FEB-2009) patient had not received the second or third dose.  It was reported that therapy with GARDASIL was discontinued in March 2008.  The patient was recovered about 2 weeks after receiving the vaccine.   The patient sought unspecified medical attention.  No further information is available.
Case number PHEH2013US020141 is an initial spontaneous report received from a practice manager on 24 SEP 2013. This report refers to a patient of an unknown age and gender. The patient received only Men CYW-135 liquid component MENVEO (batch number unknown) intramuscularly on 02 SEP 2013, without being reconstituted with Men A. Patient was revaccinated on an unknown date. No adverse event was reported following medication error.
Patient returned to store 2/28/12 upset and complaining of redness and bruising at injection site.
Shot rec'd approx 2:30-2:45   4/11/21 Headache almost at once / sore arm/ red/ swollen / stiff neck Monday  4/12/21 - awoke with temp  1000 hrs - 104 degrees  Slept all day  body ached / joints ached Tuesday 4/13/21 - 0400 hrs - temp down to  102 degrees  #2 shot was received approx. 1430-1445  4/11/2021  Headache almost at once. Arm became red, swollen and sore, and a stiff neck - right side.  Monday 4/12/2021 temp expected slight temp due to shot but by hrs it had reached 104 degrees  Slept remainder of day; awakened  drank some water, returned to bed.   Tuesday 4/13/2021 Temp was down to 102 degrees. Continued to drop thruout the day - 100.8 at 2200 hrs . Wednesday 4/14/2021 Temp nearly normal; normal by hr.  #1 Shot was received 1400 - 1415 3/15/2021. Developed a headache almost at once. Sore arm red, slight swollen - to be expected. Stiff neck. Has a slight temp, but expected. Nothing outstanding
Information has been received from a registered nurse concerning a 15 month old male who on 27, Feb 2007 was vaccinated SC with a 0.5 ml dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process) (lot# 656166/1397F) instead of a dose of measles virus vaccine live (Enders-Edmonston) (-) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (MSD). It was reported that the patient received a dose of varicella virus vaccine live (Oka/Merck (MSD) (lot # 654695/1055F) on 10, Nov 2006. Unspecified medical attention was sought. No problems were reported. There was no product quality complaint involved. No further information was provided. Additional information has been requested.
Member received Anthrax #4 Lot # FAV148 on 1Nov08. The member contacted his military unit 4Nov08 complaining of erythema, edema, pain, and tenderness extending from the top of his shoulder past his elbow. The member was advised to seek medical attention at the nearest appropriate facility. The member was contacted for follow up on 5Nov08. He received a diagnosis of "Cellulitis", received IM & PO antibiotics.
This spontaneous report as received from an other health professional refers to a 62 year old male patient. Pertinent medical history, concomitant medication, drug reactions and allergies were not provided. On 07-APR-2014 the patient was vaccinated with the expired 0.5 ml dose of PNEUMOVAX 23 in the left upper deltoid (lot # H014196, expiration date 19-MAR-2014) intramuscularly. No adverse effects reported. Additional information has been requested.
Consumer states she has a swollen lump under armpit in same are that was vaccinated. It did not appear until 2 days after injection
urticarial rash to torso & extremities;lungs clear; rest of PE WNL